Decreased circulating endothelial progenitor cells as an early risk factor of subclinical atherosclerosis in systemic lupus erythematosus

Rheumatology (United Kingdom)

Volumn 53, Issue 4, 2014, Pages 631-638

  Castejon, Raquel ^a   Jimenez ortiz, Carlos ^a   Valero gonzalez, Sara ^a   Rosado, Silvia ^a   Mellor, Susana ^a   Yebra bango, Miguel ^a  

^a HOSPITAL UNIVERSITARIO PUERTA DE HIERRO   (Spain)

Author keywords

Arterial stiffness; Endothelial progenitor cells; Subclinical atherosclerosis; Systemic lupus erythematosus

Indexed keywords

C REACTIVE PROTEIN; FIBRINOGEN;

ADULT; ARTERIAL STIFFNESS; ARTERIAL WALL THICKNESS; ARTICLE; ATHEROSCLEROSIS; B SCAN; BLOOD PRESSURE; CARDIOVASCULAR RISK; CLINICAL ARTICLE; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DISEASE ASSOCIATION; DISORDERS OF CARBOHYDRATE METABOLISM; DOPPLER FLOWMETRY; ENDOTHELIAL PROGENITOR CELL; FEMALE; FLOW CYTOMETRY; HUMAN; HYPERTENSION; METABOLIC SYNDROME X; MIDDLE AGED; PRIORITY JOURNAL; PULSE WAVE; REFERENCE VALUE; SYSTEMIC LUPUS ERYTHEMATOSUS; TOBACCO USE; YOUNG ADULT;

ARTERIAL STIFFNESS; ENDOTHELIAL PROGENITOR CELLS; SUBCLINICAL ATHEROSCLEROSIS; SYSTEMIC LUPUS ERYTHEMATOSUS;

ADULT; ASYMPTOMATIC DISEASES; ATHEROSCLEROSIS; CAROTID ARTERY DISEASES; CAROTID INTIMA-MEDIA THICKNESS; CROSS-SECTIONAL STUDIES; ENDOTHELIAL CELLS; FEMALE; FLOW CYTOMETRY; HUMANS; LUPUS ERYTHEMATOSUS, SYSTEMIC; MIDDLE AGED; PULSE WAVE ANALYSIS; RISK FACTORS; STEM CELLS; VASCULAR STIFFNESS; YOUNG ADULT;

EID: 84897874157     PISSN: 14620324     EISSN: 14620332     Source Type: Journal    
DOI: 10.1093/rheumatology/ket367     Document Type: Article

References (34)

1. Petri M, Perez-Gutthann S, Spence D et al. Risk factors for coronary artery disease in patients with systemic lupus erythematosus. Am J Med 1992;93:513-9.
2. Bruce IN, Urowitz M, Gladman D et al. Risk factors for coronary heart disease in women with systemic lupus erythematosus. Arthritis Rheum 2003;48:3159-67.
3. Rahman P, Urowitz M, Gladman D et al. Contribution of traditional risk factors to coronary artery disease in patients with systemic lupus erythematosus. J Rheumatol 1999;26:2363-8.
4. Esdaile J, Abrahamowicz M, Grodzicky T et al. Traditional Framingham risk factors fail to fully account for accelerated atherosclerosis in systemic lupus erythematosus. Arthritis Rheum 2001;44:2331-7.
5. Rajagopalan S, Somers EC, Brook RD et al. Endothelial cell apoptosis in systemic lupus erythematosus: a common pathway for abnormal vascular function and thrombosis propensity. Blood 2004;103:3677-83.
6. Asahara T, Murohana T, Sullivan A et al. Isolation of putative progenitor endothelial cells for angiogenesis. Science 1997;275:964-7.
7. Peichev M, Naiyer AJ, Pereira D et al. Expression of VEGFR-2 and AC133 by circulating human CD34(+) cells identifies a population of functional endothelial precursors. Blood 2000;95:952-8.
8. Werner N, Kosiol S, Schiegl T et al. Circulating endothelial progenitor cells and cardiovascular outcomes. N Engl J Med 2005;353:999-1007.
9. Chironi G, Walch L, Pernollet MG et al. Decreased number of circulating CD34+KDR+ cells in asymptomatic subjects with preclinical atherosclerosis. Atherosclerosis 2007;191:115-20.
10. Lee PY, Li Y, Richards HB et al. Type I interferon as a novel risk factor for endothelial progenitor cell depletion and endothelial dysfunction in systemic lupus erythematosus. Arthritis Rheum 2007;56:3759-69.
11. Westerweel PE, Luijten RK, Hoefer IE et al. Haematopoietic and endothelial progenitor cells are deficient in quiescent systemic lupus erythematosus. Ann Rheum Dis 2007;66:865-70.
12. Moonen JR, de Leeuw K, van Seijen XJ et al. Reduced number and impaired function of circulating progenitor cells in patients with systemic lupus erythematosus. Arthritis Res Ther 2007;9:R84.
13. Denny MF, Thacker S, Mehta H et al. Interferon-alpha promotes abnormal vasculogenesis in lupus: a potential pathway for premature atherosclerosis. Blood 2007;110:2907-15.
14. Grisar J, Steiner CW, Bonelli M et al. Systemic lupus erythematosus patients exhibit functional deficiencies of endothelial progenitor cells. Rheumatology 2008;47:1476-83.
15. Ebner P, Picard F, Ritcher J et al. Accumulation of VEGFR-2+/CD133+ cells and decreased number and impaired functionality of CD34+/VEGFR-2+ cells in patients with SLE. Rheumatology 2010;49:63-72.
16. Baker JF, Zhang L, Imadojemu S et al. Circulating endothelial progenitor cells are reduced in SLE in the absence of coronary artery calcification. Rheumatol Int 2012;32:997-1002.
17. Deng XL, Li XX, Liu XY. Comparative study on circulating endothelial progenitor cells in systemic lupus erythematosus patients al active stage. Rheumatol Int 2010;30:1429-36.
18. Ablin JN, Boguslavski V, Aloush V et al. Enhanced adhesive properties of endothelial progenitor cells (EPCs) in patients with SLE. Rheumatol Int 2011;31:773-8.
19. Tso TK, Huang WN, Huang HY et al. Association of brachial-ankle pulse wave velocity with cardiovascular risk factors in systemic lupus erythematosus. Lupus 2005;14:878-83.
20. Shang Q, Tam LS, Li EK et al. Increased arterial stiffness correlated with disease activity in systemic lupus erythematosus. Lupus 2008;17:1096-102.
21. Cacciapaglia F, Zardi EM, Coppolino G et al. Stiffness parameters, intima-media thickness and early atherosclerosis in systemic lupus erythematosus patients. Lupus 2009;18:249-56.
22. Distler J, Allanore Y, Avouac J et al. EUSTAR statement and recommendations on endothelial precursor cells. Ann Rheum Dis 2009;68:163-8.
23. References values for arterial stiffness collaboration. Determinants of pulse wave velocity in healthy people and in the presence of cardiovascular risk factors: 'establishing normal and references values'. Eur Heart J 2010;31:2338-50.
24. Rodriguez-Carrio J, Prado C, de Paz B et al. Circulating endothelial cells and their progenitors in systemic lupus erythematosus and early rheumatoid arthritis patients. Rheumatology 2012;51:1175-84.
25. Clancy R, Marder G, Martin V et al. Circulating activated endothelial cells in systemic lupus erythematosus: further evidence for diffuse vasculopathy. Arthritis Rheum 2001;44:1203-8.
26. Robak E, Kierstan M, Cebula B et al. Circulating endothelial cells and angiogenic proteins in patients with systemic lupus erythematosus. Lupus 2009;18:332-41.
27. Elshal M, Abdelaziz A, Abbas A et al. Quantification of circulating endothelial cells in peripheral blood of systemic lupus erythematosus patients: a simple and reproducible method of assessing endothelial injury and repair. Nephrol Dial Transpl 2009;24:1495-9.
28. Doria A. Atherosclerosis and lupus: what we know and what we should know. J Rheumatol 2009;36:2380-2.
29. Oliveras A, Soler MJ, Martínez-Estrada OM et al. Endothelial progenitor cells are reduced in refractory hypertension. J Hum Hypertens 2008;22:183-90.
30. Umemura T, Soga J, Hidaka T et al. Aging and hypertension are independent risk factors for reduced number of circulating endothelial progenitor cells. Am J Hypertens 2008;21:1203-9.
31. Vasa M, Fichtlscherer S, Aicher A et al. Number and migratory activity of circulating endothelial progenitor cells inversely correlate with risk factors for coronary artery disease. Circ Res 2001;89:E1-7.
32. Choi JH, Kim KL, Huh W et al. Decreased number and impaired angiogenic function of endothelial progenitor cells in patients with chronic renal failure. Arterioscler Thromb Vasc Biol 2004;24:1246-52.
33. Kluz J, Kopec W, Jakobsche-Policht U et al. Circulating endothelial cells, endothelial apoptosis and soluble markers of endothelial dysfunction in patients with systemic lupus erythematosus-related vasculitis. Int Angiol 2009;28:192-201.
34. Liu Y, Wei J, Hu S et al. Beneficial effects of statins on endothelial progenitor cells. Am J Med Sci 2012;344:220-6.